✦ LIBER ✦

Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea

✍ Scribed by Hyun Soon Sohn; Tae-Jin Lee; Jinhyun Kim; Donghwan Kim

Book ID: 113543982
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 137 KB
Volume: 31
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2009.05.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of antifunga

Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation

✍ Warren Schonfeld; J. Wang Cheng; Kuo B. Tong; Raafat Seifeldin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Use of micafungin versus fluconazole for

Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation

✍ Yasushi Hiramatsu; Yoshinobu Maeda; Nobuharu Fujii; Takashi Saito; Yuichiro Nawa 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 231 KB

243Pharmacoeconomics of prophylaxis for

243Pharmacoeconomics of prophylaxis for fungal infections in patients undergoing a hematopoietic stem cell transplant

✍ K.B. Tong 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Cost-effectiveness of posaconazole versu

Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease

✍ O'Sullivan, A. K.; Weinstein, M. C.; Pandya, A.; Thompson, D.; Langston, A. A.; 📂 Article 📅 2012 🏛 American Society of Health-System Pharmacists 🌐 English ⚖ 266 KB

PIN16 COST-EFFECTIVENESS OF POSACONAZOLE

PIN16 COST-EFFECTIVENESS OF POSACONAZOLE VS. FLUCONAZOLE IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH GRAFT-VERSUS-HOST DISEASE IN CANADA

✍ AA Tahami Monfared; AK O'Sullivan; G Papadopoulos 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Posaconazole versus fluconazole or itrac

Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis

✍ George Dranitsaris; Haytham Khoury 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 217 KB